Long-term results of a phase II clinical trial of superantigen therapy with staphylococcal enterotoxin C after microwave ablation in hepatocellular carcinoma

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108
   PubMed Web of Science ®Google Scholar
• Bruix J, Hessheimer AJ, Forner A, Vilana R, Llovet JM. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 2006; 25: 3848–3856
   PubMed Web of Science ®Google Scholar
• Bruix J, Fuster J, Llovet JM. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003; 9: 700–702
   PubMed Web of Science ®Google Scholar
• Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299–307
   PubMed Web of Science ®Google Scholar
• Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961–967
   PubMed Web of Science ®Google Scholar
• Dong BW, Liang P, Yu X, Su L, Yu D, Cheng Z, Zhang J. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: Results in 234 patients. AJR 2003; 180: 1547–1555
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, et al. Surgical resection versus percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49: 589–594
   PubMed Web of Science ®Google Scholar
• Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol 2007; 37: 658–672
   PubMed Web of Science ®Google Scholar
• Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: Is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?. Radiology 2009; 252: 905–13
   PubMed Web of Science ®Google Scholar
• Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M, Kokubu S, Saigenji K. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: Risk factors and patterns. J Gastroenterol 2008; 43: 71–78
   PubMed Web of Science ®Google Scholar
• Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008; 207: 20–29
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208–1236
   PubMed Web of Science ®Google Scholar
• Milich DR, Jones J, Hughes J, Maruyama T. Hepatitis B virus infection, the immune response and hepatocellular carcinoma. Ciba Found Symp 1994; 187: 113–129
   PubMedGoogle Scholar
• Cerny A, Chisari FV. Immunological aspects of HCV infection. Intervirology 1994; 37: 119–125
   PubMed Web of Science ®Google Scholar
• Takagi S, Chen K, Schwarz R, Iwatsuki S, Herberman RB, Whiteside TL. Functional and phenotypic analysis of tumour infiltrating lymphocytes isolated from human primary and metastatic liver tumours and cultured in recombinant interleukin-2. Cancer 1989; 63: 102–111
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M, Grizzi F, Wachtel MS, et al. Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci 2008; 53: 836–843
   PubMed Web of Science ®Google Scholar
• Coley WB. The treatment of malignant tumours by repeated inoculations of erysipelas with a report of 10 original cases. Am J Med Sci 1893; 105: 487–511
   Google Scholar
• White J, Andrew H, Ann M, Iwatsuki S, Herberman RB, Whiteside TL. The Vβ-specific superantigen staphloccoal enterotoxin: Stimulation of nature T cells and colonal deletion in neonatal mice. Cell 1989; 56: 27–35
   PubMed Web of Science ®Google Scholar
• Hedlund G, Dohlsten M, Petersson C, Kalland T. Superantigen-based tumor therapy: In vivo activation of cytotoxic T cells. Cancer Immunol Immunother 1993; 36: 89–93
   PubMed Web of Science ®Google Scholar
• Lamphear JG, Bohach GA, Rich RR. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes. J Immunol 1998; 160: 2107–2114
   PubMed Web of Science ®Google Scholar
• Inoue M, Plautz GE, Shu S. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells. Cancer Research 1996; 56: 4702–4708
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Zeuthen J, Lund B, Persson B, Alenfall J, Hansen HH. Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma. J Immunother 2000; 23: 146–153
   PubMed Web of Science ®Google Scholar
• Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, Wang XD, Xin H, Li S. Sonographically guided microwave coagulation treatment of liver cancer: An experimental and clinical study. Am J Roentgenol 1998; 171: 449–454
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun Y, Feng L, Gao Y, Ni X, Liang P. Internally cooled antenna for microwave ablation: Results in ex vivo and in vivo porcine livers. EJR 2008; 67: 357–361
   Google Scholar
• Liu FY, Yu XL, Liang P, Wang Y, Zhou P, Yu J. Comparison of percutaneous 915 MHz microwave ablation and 2450 MHz microwave ablation in large hepatocellular carcinoma. Int J Hyperthermia 2010; 26: 448–455
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Charboneau JW, Dodd GD, III, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT, Jr, Livraghi T, McGahan JP, et al. Image-guided tumor ablation: Proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335–345
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: Treatment with percutaneous microwave ablation - complications among cohort of 1136 patients. Radiology 2009; 251: 933–940
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of Focal Heat Destruction of Liver Tumors. Journal of Surgical Research 2005; 127: 208–223
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Malcontenti-Wilson C, Christophi C. Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects. J Gastrointest Surg 2005; 9: 410–417
   PubMed Web of Science ®Google Scholar
• Mihich E. Biological response modifiers: Their potential and limitations in cancer therapeutics. Cancer Invest 1985; 3: 71–83
   PubMed Web of Science ®Google Scholar
• Isbert C, Ritz JP, Roggan A, Schuppan D, Rühl M, Buhr HJ, Germer CT. Enhancement of the immune response to residual intrahepatic tumor tissue by laser induced thermotherapy (LITT) compared to hepatic resection. Lasers Surg Med 2004; 35: 284–292
   PubMed Web of Science ®Google Scholar
• Dickson JA, Shah SA. Hyperthermia: The immune response and tumor metastasis. Natl Cancer Inst Monogr 1982; 61: 183–192
   PubMedGoogle Scholar
• Mondovì B, Santoro AS, Strom R, Faiola R, Fanelli AR. Increased immunogenicity of Ehrlich ascites cells after heat treatment. Cancer 1972; 30: 885–888
   PubMed Web of Science ®Google Scholar
• Wu F, Zhou L, Chen WR. Host antitumour immune responses to HIFU ablation. Int J Hyperthermia 2007; 23: 165–171
   PubMed Web of Science ®Google Scholar
• Dohlsten M, Hedlund G, Akerblom E, Lando PA, Kalland T. Monoclonal antibody-targeted superantigens: A different class of anti-tumor agents. Proc Natl Acad Sci USA 1991; 88: 9287–9291
   PubMed Web of Science ®Google Scholar
• Dohlsten M, Sundstedt A, Bjorklund M, Hedlund G, Kalland T. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 1993; 54: 482–488
   Google Scholar
• Litton MJ, Dohlsten M, Lando PA, Kalland T, Ohlsson L, Andersson J, Andersson U. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. Eur J Immunol 1996; 26: 1–9
   PubMed Web of Science ®Google Scholar
• Dong B, Zhang J, Liang P, Yu XL, Su L, Yu DJ, Ji XL, Yu G. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hyperthermia 2003; 19: 119–133
   PubMed Web of Science ®Google Scholar
• Zhang J, Dong B, Liang P, Yu XL, Su L, Yu DJ, Ji XL, Yu G. Significance of changes in local immunity in patients with hepatocellular carcinoma after percutaneous microwave coagulation therapy. Chin Med J (Engl) 2002; 115: 1367–1371
   PubMed Web of Science ®Google Scholar
• Jie K, Jiang H, Sun L, Wang HR, Zheng YL, Li Y, Jiang YQ. The pilot study of anti-tumor effects versus immunosuppression of staphylococcal enterotoxin C. Cancer Biol Therapy 2007; 6: 1584–1591
   PubMed Web of Science ®Google Scholar
• Seo KS, Lee SU, Park YH, Davis WC, Fox LK, Bohach GA. Long-term staphylococcal enterotoxin C1 exposure induces soluble factor-mediated immunosuppression by bovine CD4+ and CD8+ T cells. Infect Immun 2007; 75: 260–269
   PubMed Web of Science ®Google Scholar
• McCormack JE, Callahan JE, Kappler J, Marrack PC. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 1993; 150: 3785–3792
   PubMed Web of Science ®Google Scholar